The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
DTRI Supplemental Award [Duke Internal Funding -- For Duke Faculty Only]
The Duke Translational Research Institute (DTRI) is the academic home of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) pilot funding program. The DTRI accelerates translational research, from discovery to preclinical and human trials, and on to implementation into practice or commercialization. DTRI supports translational research not only by providing funding, but also by promoting investigator collaboration, encouraging innovation, providing project management assistance, and providing access to resources/services in a collaborative and service- oriented fashion.
The DTRI Supplemental Award for NIH/PHS Projects provides funding up to $25,000 (direct costs only) to support use of an unanticipated technology, collaboration, or resource discovered to be needed during innovative, NIH-funded or similar PHS-funded, translational research. Examples include, but are not limited to, funding to purchase, process, and store samples for a repurposing study or to develop the statistical plan and conduct the initial analysis for an ancillary sub-study to the parent grant. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels. Population health improvement projects should demonstrate significant stakeholder involvement to move it more globally into broader practice patterns, clinical guidelines, and other applications.
Deadline: Jan. 7, 2016
Duke Principal Investigators of active NIH (U-, P-, or R-funding mechanism) or similar PHS research projects funded at least through April 30, 2017 are eligible to apply. This funding date should represent the actual funding period and should not include any no-cost extension (NCE) periods.